Back
Avenue Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
17
ATXI
Avenue Therapeutics
Last Price:
2.05
Seasonality Move:
0.6%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATXI is experiencing selling pressure, which indicates risk of future bearish movement.
Avenue Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.96 | Buy |
| 20-day SMA: | 2.14 | Sell |
| 50-day SMA: | 2.23 | Sell |
| 200-day SMA: | 5.19 | Sell |
| 8-day EMA: | 2 | Buy |
| 20-day EMA: | 2.08 | Sell |
| 50-day EMA: | 2.27 | Sell |
| 200-day EMA: | 12.35 | Sell |
Avenue Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 44.01 | Sell |
| Chaikin Money Flow: | -36506 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.95 - 2.31) | Sell |
| Bollinger Bands (100): | (2.1 - 3.06) | Sell |
Avenue Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Avenue Therapeutics Stock
Is Avenue Therapeutics Stock a Buy?
- Avenue Therapeutics share price is 2.01 while ATXI 8-day simple moving average is 1.96, which is a Buy signal.
- The stock price of ATXI is 2.01 while Avenue Therapeutics 20-day SMA is 2.14, which makes it a Sell.
- Avenue Therapeutics 50-day simple moving average is 2.23 while ATXI share price is 2.01, making it a Sell technically.
- ATXI stock price is 2.01 and Avenue Therapeutics 200-day simple moving average is 5.19, creating a Sell signal.
ATXI Technical Analysis vs Fundamental Analysis
Sell
17
Avenue Therapeutics (ATXI)
is a Sell
Is Avenue Therapeutics a Buy or a Sell?
-
Avenue Therapeutics stock is rated a Sell
The current Avenue Therapeutics [ATXI] share price is $2.01. The Score for ATXI is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
Avenue Therapeutics Stock Info
Market Cap:
3.84M
Price in USD:
2.01
Share Volume:
45.63K
Avenue Therapeutics 52-Week Range
52-Week High:
26.47
52-Week Low:
1.60
Sell
17
Avenue Therapeutics (ATXI)
is a Sell
Avenue Therapeutics Share Price Forecast
-
What is the Avenue Therapeutics stock price today?
The Avenue Therapeutics stock price is 2.01 USD today. -
Will ATXI stock go up or go down?
Avenue Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Avenue Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Avenue Therapeutics is overvalued.
Is Avenue Therapeutics Stock a Buy?
- Avenue Therapeutics share price is 2.01 while ATXI 8-day exponential moving average is 2.00, which is a Buy signal.
- The stock price of ATXI is 2.01 while Avenue Therapeutics 20-day EMA is 2.08, which makes it a Sell.
- Avenue Therapeutics 50-day exponential moving average is 2.27 while ATXI share price is 2.01, making it a Sell technically.
- ATXI stock price is 2.01 and Avenue Therapeutics 200-day simple moving average is 12.35, creating a Sell signal.
Technical Analysis of Avenue Therapeutics
Should I short Avenue Therapeutics stock?
- ATXI Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Avenue Therapeutics is a Sell
- Avenue Therapeutics Relative Strength Index (RSI) is 44.01, which suggest Avenue Therapeutics is oversold
- The Bollinger Bands (25) for Avenue Therapeutics is (1.95 - 2.31), which suggest Avenue Therapeutics is a Sell
- The Bollinger Bands (100) for Avenue Therapeutics is (2.1 - 3.06), which suggest Avenue Therapeutics is a Sell
* Avenue Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.